Clinical Trials on Soil-Transmitted Helminth Infection

Total 5371 results

Gilead Sciences

Completed

A Prospective, Observational Study of Pregnancy Outcomes Among Women Exposed to Truvada for PrEP Indication

HIV Infection

United States
Richard Crosby
University of Mississippi Medical Center

Completed

A Pilot Study of PrEP Acceptance Among Young Black MSM (MI-PrEP)

HIV Infection
ANRS, Emerging Infectious Diseases

Completed

Viral Biofilms: Hijacking T Cell Extracellular Matrix to Regulate HIV-1 Spread? (TRANSBioHIV)

HIV Infection

France
University of North Carolina, Chapel Hill
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM)

HIV Infection

United States
Hennepin Healthcare Research Institute

Terminated

Aspirin and Antiretroviral Therapy in HIV Infected Patients

HIV Infection

United States
Judit Pich Martínez

Completed

A Phase I, Open Label Dose Escalation Study to Evaluate Safety of iHIVARNA-01 in Chronically HIV-infected Patients Under Stable Combined Antiretroviral Therapy

HIV-infection

Spain
University of Pennsylvania

Completed

Pharmacokinetic Characteristics and Anti-Inflammatory Effects of Aprepitant In HIV-Infected Subjects (Emend-IV)

HIV Infection

United States
ANRS, Emerging Infectious Diseases
Janssen Pharmaceuticals

Completed

Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa (MOBIDIP)

HIV Infection

Cameroon, Burkina Faso, Senegal
National Institutes of Health Clinical Center (CC)

Completed

Differences in Blood Levels of Nevirapine in HIV-infected Patients in Uganda and the United States

HIV Infection

United States, Uganda
St Stephens Aids Trust

Completed

Study in Healthy Volunteers of the Safety and Metabolism of Different Doses of the Anti-HIV Drug TMC278LA.

HIV Infection

United Kingdom
Fenway Community Health
Harvard Medical School (HMS and HSDM); Massachusetts General Hospital; Boston...

Completed

Improving Antiretroviral Medication Adherence Among HIV-infected Youth

HIV Infection

United States
Drexel University

Completed

Immune Activation and Drug Absorption in HIV-Infected Patients

HIV Infection

United States
ViiV Healthcare

Completed

A Clinical Study Of An Investigational Regimen Including Marketed HIV Drugs In HIV-1 Pediatric Subjects Ages 2-18 Years

HIV Infection

United States, Spain, Portugal, Italy, Romania, Canada, Netherlands
University of North Carolina, Chapel Hill
National Institute on Drug Abuse (NIDA); National Institute on Alcohol Abuse... and other collaborators

Completed

Typology of Adherence in Adolescents: Phase II

HIV Infection

United States, Puerto Rico
University of North Carolina, Chapel Hill

Completed

Connect to Protect (C2P): Building a Community-Based Infrastructure for HIV Prevention

HIV Infection

United States
University of North Carolina, Chapel Hill
National Institute on Drug Abuse (NIDA); National Institute of Mental Health...

Completed

Factors Affecting PrEP Adherence

HIV Infection

United States
University of North Carolina, Chapel Hill
National Institute on Drug Abuse (NIDA); National Institute of Mental Health...

Withdrawn

Trial of Probiotics to Lower Microbial Translocation and Immune Activation in HIV-Infected Adolescents

HIV Infection
Makerere University
University of Oxford; Case Western Reserve University

Unknown

Statin Adjunct Therapy Among ART-treated Adults in Sub-Saharan Africa: Atorvastatin and Rosuvastatin Equivalence Trial (STAR)

HIV Infection
ANRS, Emerging Infectious Diseases

Completed

Evaluation of a Dose Reduction of Darunavir (400 mg/d) in Virologically Suppressed HIV-1 Patients (DARULIGHT)

HIV INFECTION

France
Massachusetts General Hospital

Completed

Physiologic Investigation of the Renin Angiotensin Aldosterone Axis in HIV

HIV-infection

United States
Gilead Sciences

Completed

Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus Raltegravir

HIV Infection

Canada, Germany, United States, Spain, France, Australia, Puerto Rico, Italy, Belgium, Mexico, Switzerland, Portugal, Netherlands, United Kingdom
Barbara Ensoli, MD

Completed

Observational Study on Anti-Tat Immune Response in HIV-1-infected HAART-treated Adult Subjects (ISS OBS T-002)

HIV Infection

Italy
Center for Primary Care and Public Health (Unisante)...
Gilead Sciences; Centre Hospitalier Universitaire Vaudois; Swiss HIV Cohort Study

Completed

Tenofovir, Emtricitabine and Efavirenz Late Switch to a Single Pill: Patients' Opinion Survey

HIV Infection

Switzerland
St. Jude Children's Research Hospital

Completed

Human Immune Responses Toward HIV-1 Envelope Antigens (HIVBLD)

HIV Infection

United States
Ottawa Hospital Research Institute
Bristol-Myers Squibb

Completed

Microboosting of Atazanavir 300 mg With 50 mg Versus 100mg Ritonavir Daily in HIV-infected Patients: a Pharmacokinetic Study

HIV Infection

Canada
CONRAD
United States Agency for International Development (USAID); Bill and Melinda...

Terminated

Cellulose Sulfate and HIV Transmission Among Women

HIV Infection

India, South Africa, Benin, Uganda
Merck Sharp & Dohme LLC

Completed

Stocrin Re-examination Study (0831-028)

HIV Infection
Tibotec Pharmaceuticals, Ireland

Completed

TMC114-C214: Trial of TMC114 Administered With Low Dose Ritonavir (RTV) in HIV-1 Infected Treatment Experienced Patients

HIV Infection

United States, Australia, France, United Kingdom, Belgium, Germany, Spain, Argentina, Chile, Mexico, Portugal, Malaysia, Panama, South Africa, Canada, Netherlands, Brazil, Puerto Rico, Austria, Russian Federation, Thailand, Hungary, Denmar... and more
ANRS, Emerging Infectious Diseases

Completed

X-linked Biological Response to HIV Sensing: the ANRS EP 53 Study (X LIBRIS)

Hiv Infection

France
Fundacion SEIMC-GESIDA
Bristol-Myers Squibb

Completed

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy (SALT)

HIV Infection

Spain
Columbia University
National Institute of Mental Health (NIMH)

Completed

Evaluating a Microfinance Intervention for High Risk Women in Mongolia

HIV Infection

Mongolia
Fundación FLS de Lucha Contra el Sida, las Enfermedades...

Completed

First Study to Evaluate the Capacity of Maraviroc Drug to Protect Against HIV Infection in Samples of Rectal Mucosa From Healthy Volunteers

HIV

Spain
Bristol-Myers Squibb
PENTA Foundation

Completed

Post-marketing Safety Surveillance Program in Human Immunodeficiency Virus (HIV)-Infected Children Exposed to Atazanavir in Europe

HIV Infection

Romania, Belgium, Germany, Italy, Spain, Switzerland, United Kingdom
St George's, University of London

Completed

Community-Based Trial of Screening for Chlamydia Trachomatis to Prevent Pelvic Inflammatory Disease (POPI)

Chlamydia Infections | Pelvic Inflammatory Disease

United Kingdom
Indiana University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Comparing Blood Vessel Endothelial Function in HIV-Infected People and Matched HIV-Uninfected People

HIV Infection

United States
Hopital Lariboisière

Completed

Antiretroviral Therapy and Extreme Weight (EXTATIC)

HIV Infection

France
Kirby Institute
Chelsea and Westminster NHS Foundation Trust

Completed

The Intensive Pharmacokinetics Sub-study of Encore1 (ENCORE1-PK)

HIV Infection

Argentina, South Africa, Thailand, United Kingdom
Genetic Immunity

Completed

Single DermaVir Immunization in HIV-1 Infected Patients on HAART (GIHU004)

HIV Infection

Hungary
Bavarian Nordic
National Institutes of Health (NIH)

Completed

An Evaluation of Immunogenicity and Safety of Two Doses of MVA-nef vs. MVA-BN in HIV-1 Infected Patients

HIV Infection

Germany
Oslo University Hospital
Eurocine Vaccines AB; Bionor Immuno AS

Completed

Intranasal Modified Vacc-4x Gag Peptides With Endocine as Adjuvant

HIV Infection

Norway
Gilead Sciences

Completed

Safety and Efficacy Study of Switching From Epzicom to Truvada (SWIFT)

HIV Infection

United States, Puerto Rico, Canada
Abbott
Lincoln Medical and Mental Health Center; Readitwell

Completed

Evaluation of the Public Health Interest of Kaletra: Impact on Resistance to Antiretrovirals (ARVs) (EOLE)

HIV Infection

France
International AIDS Vaccine Initiative

Completed

A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-risk Populations in Uganda, Africa

HIV Infection

Uganda
Boston Medical Center
National Institutes of Health (NIH); United States Agency for International...

Completed

Zambia Exclusive Breastfeeding Study

HIV Infection

Zambia
Tibotec Pharmaceuticals, Ireland

Completed

TMC125-C227: A Phase II Randomized, Active-Controlled, Open Label Trial to Investigate the Efficacy and Tolerability of TMC125 in HIV-1 Infected Subjects, Who Are PI-Naive and With Documented Genotypic Evidence of NNRTI Resistance From Previous NNRTI Use

HIV Infection
Bristol-Myers Squibb

Completed

Effect of the Atazanavir (ATV) 150L Mutation on Subsequent Treatment Response in HIV Infected Subjects

HIV Infection

United States, Argentina, Brazil, Guatemala, Mexico, Peru, South Africa
Centre Hospitalier Universitaire de Nice

Unknown

Impact of Raltegravir on the Viral Reservoirs

HIV Infection

France
St Stephens Aids Trust

Withdrawn

Depot Contraception With and Without Lopinavir/Ritonavir

HIV Infection

United Kingdom
GlaxoSmithKline

Completed

A Healthy Volunteer And Patient Study To Assess The Safety, Tolerability And Pharmacokinetics Of GSK1265744

HIV Infection

United States
GlaxoSmithKline

Completed

A Study Comparing Safety Of Abacavir And Lamivudine Administered Once-Daily As A Single Tablet Versus The Same Drugs Administered Twice-Daily As Separate Tablets (ALOHA Study)

HIV Infection

United States

Clinical Trials on Soil-Transmitted Helminth Infection

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations